Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients

Respiratory Medicine

Volumn 90, Issue 1, 1996, Pages 35-38

  Fujita, J ^a,b   Yamadori, I ^a   Xu, G ^a   Hojo, S ^a   Negayama, K ^a   Miyawaki, H ^a   Yamaji, Y ^a   Takahara, J ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; LATAMOXEF; MINOCYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; STENOTROPHOMONAS MALTOPHILIA; TUMOR;

EID: 0029972486     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(96)90242-5     Document Type: Article

References (17)

1. Gilardi GL, Pseudomonas maltophilia infections in man. Am J Clin Pathol 1969; 51: 58-61.
2. Harlowe HD. Acute mastoiditis following Pseudomonas maltophilia infection: case report. Laryngoscope 1972; 82: 882-883.
3. Sutter VL. Identification of Pseudomonas species isolated from hospital environment and human sources. Appl Environ Microbiol 1968; 16: 1532-1538.
4. Ben-Tovim T, Eylan E, Romano A, Stein R. Gramnegative bacteria isolated from external eye infections. Infection 1974; 2: 162-165.
5. Gardner P, Griffin WB, Swartz MN, Kunz LJ. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med 1970; 48: 735-749.
6. Sonnenwirth AC. Bacteremia with and without meningitis due to Yersinia enterocolitica, Edwardsiella tarda, Comamonas terrigena, and Pseudomonas maltophilia. Ann NY Acad Sci 1970; 174: 488-502.
7. Zuravleff JJ, Yu VL. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis 1982; 4: 1236-1246.
8. Sarkar TK, Gilardi G, Aguam AS, Josephson J, Leventhal GL. Primary Pseudomonas maltophilia infection of the lung. Postgrad Med 1979; 65: 253-256.
9. Wilson WR, Gilbert DN, Bisno AL et al. General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin Infect Dis 1992; 15 (Suppl. 1): 62-88.
10. Irifune K, Ishida T, Shimoguchi K et al. Pneumonia caused by Stenotrophomonas maltophilia with a mucoid enotype. J Clin Microbiol 1994; 32: 2856-2857.
11. Marshall WF, Keating MR, Anhalt JP, Steckelberg JM, Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc 1989; 64: 1097-1104.
12. Park SY, Parker RH. Review of imipenem. Infect Control 1986; 7: 333-337.
13. Jones RN. Review of the in vitro spectrum of activity of imipenem. Am J Med 1985; 78: 22-32.
14. Eliting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11: 134-138.
15. Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990; 12: 997-1003.
16. Schable B, Villarino ME, Favero MS, Miller JM. Application of multilocus enzyme electrophoresis to epidemiologic investigations of Xanthomonas maltophilia. Infect Control Hosp Epidemiol 1991; 12: 163-167.
17. Felegie TP, Yu VL, Rumans LM, Yee RB. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 1979; 16: 833-837.